Search Results - Natasja Hendriks
- Showing 1 - 2 results of 2
-
1
Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia – A case series by Tirza Wouters, Natasja Hendriks, Margot Koeneman, Arnold-Jan Kruse, Anna van de Sande, Heleen J. van Beekhuizen, Kees G. Gerestein, Ruud L.M. Bekkers, Jurgen M.J. Piek
Published in Case Reports in Women's Health (2019-01-01)Get full text
Article -
2
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions by Natasja Hendriks, Sjoerd H van der Burg, Ziena Abdulrahman, Noel F C C de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Antonios Somarakis, Arnold J Kruse, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Loes F S Kooreman, Brigitte F M Slangen
Published in Journal for ImmunoTherapy of Cancer (2022-11-01)Get full text
Article
